Public Research Library
Specialties:
Most Popular Reports:
- Laser Body Sculpting SmartLipo-Trends in Use
- Essure Permanent Birth Control
- Oral Contraceptives Market Evaluation
- Trends and Forecast of Dental Implant Cases
- Avastin and the AVADO Trial Survey
Newest Reports:
Stereotactic Radiosurgery: Market Assessment
A Panel Discussion Among Ten Radiation Oncologists
Study Description and Objectives
Engage a panel of radiation oncologists to understand how specific manufacturers (Varian, TomoTherapy, Elekta, Accuray) compare in the stereotactic market
§ Understand current use of stereotactic radiosurgery (SRS)
§ Identify the major players and most important attributes involved in decisions regarding the purchase of equipment for stereotactic radiosurgery
§ Determine the barriers and facilitators to using stereotactic radiosurgery, and how companies can better serve these markets with products and/or services
§ Estimate trends in use and market dynamics over the next 1-3 years
§ Compare Cyberknife (Accuray – stereotactic radiosurgery) to Hi Art (TomoTherapy - IMRT)
o Impact of reimbursement differences
o Perception of market positioning and interchangeability of SRS and IMRT
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
Elekta |
Elekta B |
Gamma Knife® |
|
Accuray |
ARAY |
Cyberknife® |
|
Brain Lab |
|
Novalis® |
|
Varian |
VAR |
Trilogy™ |
|
TomoTherapy |
TTPY |
Hi Art® |
Inclusion Criteria
|
Inclusion Criteria
|
§ 10 US-based board-certified radiation oncologists § 2 to 30 years work experience § Work in academic or large hospital setting § High volume of SRS use |
Hospitals Represented
§ Christiana Care Health System, DE
§ Arkansas Cancer Institute, AR
§
§
§ Arnot Ogden Medical Center, NY
§
§
§
§
§
Reports become free one year after the publication date.
 about us contact us |
 |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |